EXPB10 Antibody

What is EXPB10 and what organisms express this protein?

EXPB10 (Expansin B10) is a β-expansin protein found primarily in grasses. It belongs to the expansin family of proteins that play crucial roles in plant cell wall loosening and expansion. In rice (Oryza sativa), EXPB10 consists of 245 amino acids (positions 23-267) and is predominantly expressed in specific tissues . In maize (Zea mays), EXPB10 is one of four major pollen-specific proteins, alongside EXPB1, EXPB9, and EXPB11, collectively referred to as Zea m 1 allergens .

The expression pattern of EXPB10 is highly tissue-specific, with analysis of EST databases indicating that EXPB10 and the related EXPB11 are well-represented in pollen and anther-specific libraries but not found in other tissues . This tissue-specific expression pattern suggests specialized functions related to reproductive processes in grasses.

What is the structural relationship between EXPB10 and other expansin family members?

EXPB10 shares significant sequence homology with other β-expansins. Specifically, EXPB10 and EXPB11 proteins are approximately 94% identical to each other, indicating recent gene duplication . They also share approximately 70% sequence identity with Lol p 1, a major grass pollen allergen . Comparatively, they have about 62% sequence identity with EXPB1 and EXPB9 .

Structurally, β-expansins like EXPB10 typically contain two domains: Domain 1 (D1) with structural similarity to glycoside hydrolase family 45 (GH45) enzymes, and Domain 2 (D2) with an immunoglobulin-like fold similar to grass pollen allergens . While the crystal structure of EXPB10 itself has not been explicitly described in the provided research, the structure of the related EXPB1 has been determined and likely provides insights into EXPB10's structure due to their homology .

What are the recommended approaches for producing and purifying EXPB10 antibodies?

Production of high-quality EXPB10 antibodies typically follows these methodological steps:

• Antigen preparation: Recombinant EXPB10 can be expressed in systems such as yeast, resulting in proteins like the His-tagged EXPB10 (AA 23-267) described in the research . The yeast expression system is particularly advantageous as it enables post-translational modifications similar to those in plants, ensuring that the recombinant protein maintains conformational epitopes .

• Immunization protocol: Based on established hybridoma technology approaches, immunization typically involves:

  • Primary immunization with purified recombinant EXPB10

  • Booster injections with cells expressing EXPB10

  • This whole-cell immunization method helps maintain the intact structure of antigens with native conformation during antibody selection

• Antibody production: Following successful immunization, B cells from the spleen can be isolated and fused with immortalized myeloma cells to create hybridoma clones that continuously secrete the desired anti-EXPB10 antibodies .

• Purification: Antibodies can be purified by affinity chromatography using protein A Sepharose, similar to methods described for other antibody production systems .

How can the specificity of EXPB10 antibodies be validated experimentally?

Validation of EXPB10 antibody specificity is critical for research applications and should include multiple approaches:

• Western blotting: Test the antibody against recombinant EXPB10 alongside related expansins (EXPB1, EXPB9, EXPB11) to confirm specific recognition of EXPB10 and assess potential cross-reactivity.

• ELISA-based specificity testing: Determine binding affinity to recombinant EXPB10 versus other expansin family members. The ELISA approach is particularly useful as EXPB10 antibodies have demonstrated applications in this technique .

• Immunohistochemistry control experiments: Include:

  • Positive controls using tissues known to express EXPB10 (e.g., pollen tissues)

  • Negative controls using tissues that don't express EXPB10

  • Absorption controls where the antibody is pre-incubated with recombinant EXPB10 protein

• Knockout/knockdown validation: When possible, test the antibody against samples from EXPB10 knockout/knockdown plants to confirm specificity.

How can antibody microarrays be optimized for EXPB10 expression profiling across different plant tissues?

Protein expression microarrays (antibody arrays) represent a powerful technology for assessing EXPB10 expression levels directly across various tissues and conditions . Optimization involves:

• Experimental design considerations:

  • Use two-color antibody arrays with appropriate reference samples

  • Include technical and biological replicates

  • Implement dye-swap experiments to control for dye-specific biases

• Normalization procedures:

  • Apply normalization methods developed for cDNA arrays to eliminate systematic bias

  • Consider global normalization or localized intensity-dependent normalization (e.g., LOWESS)

• Statistical analyses:

  • Use appropriate statistical methods to assess differential expression

  • Apply classification algorithms to identify expression patterns across conditions

  • Consider methods such as significance analysis of microarrays (SAM) that control false discovery rates

• Validation:

  • Confirm microarray findings with orthogonal methods such as Western blotting or immunohistochemistry

  • Compare protein expression data with transcriptomic data where available

What methodological approaches can distinguish between EXPB10 and other closely related expansins in experimental settings?

Distinguishing between EXPB10 and highly similar proteins (especially EXPB11, with 94% sequence identity) requires specialized approaches:

• Epitope mapping and antibody development:

  • Identify unique epitopes in EXPB10 that differ from EXPB11 and other family members

  • Develop antibodies against these unique regions

  • Use peptide competition assays to confirm specificity

• High-resolution techniques:

  • Employ mass spectrometry-based proteomics to distinguish between EXPB10 and related proteins based on unique peptide signatures

  • Use selective reaction monitoring (SRM) mass spectrometry to target peptides specific to EXPB10

• Domain-specific antibodies:

  • Develop antibodies specific to regions that differ between EXPB10 and EXPB11

  • Consider generating antibodies against post-translational modifications unique to EXPB10

• Comparative analysis framework:

  • When absolute specificity cannot be achieved, implement comparative analysis across multiple antibodies with known cross-reactivity profiles

  • Use mathematical modeling to deconvolute signals from cross-reactive antibodies

How can EXPB10 antibodies be used to investigate structure-function relationships in plant cell walls?

EXPB10 antibodies can be powerful tools for understanding the structural basis of expansin function in cell wall modification:

• Immunolocalization studies:

  • Use EXPB10 antibodies for high-resolution localization within cell walls using techniques like immunogold electron microscopy

  • Track dynamic changes in EXPB10 localization during cell expansion events

  • Implement dual-labeling with cell wall polysaccharide-specific antibodies to identify interaction domains

• Functional domain mapping:

  • Generate antibodies against specific functional domains (e.g., the putative polysaccharide-binding domain or catalytic domain)

  • Use these domain-specific antibodies to block function in in vitro cell wall extension assays

  • Compare results with structural data from related expansins like EXPB1

• Protein-substrate interaction analysis:

  • Use antibodies in co-immunoprecipitation experiments to identify interacting partners

  • Employ proximity ligation assays to detect in situ interactions between EXPB10 and cell wall components

  • Based on the structural insights from related expansins, investigate potential binding to arabinoxylans in grass cell walls

What techniques can resolve contradictions in EXPB10 antibody-based experimental results?

When facing contradictory results using EXPB10 antibodies, researchers should implement these methodological approaches:

• Antibody characterization and validation:

  • Thoroughly characterize antibodies for specificity, sensitivity, and potential cross-reactivity

  • Validate across multiple experimental systems and conditions

  • Use multiple antibodies raised against different epitopes of EXPB10

• Sample preparation considerations:

  • Investigate whether differences in sample preparation affect epitope accessibility

  • Test multiple fixation and extraction protocols to optimize antigen preservation

  • Consider native versus denatured conditions for antibody recognition

• Quantitative analysis approaches:

  • Implement rigorous statistical analysis of results

  • Use appropriate controls and technical replicates

  • Consider dose-response experiments to establish detection thresholds and dynamic ranges

• Complementary techniques:

  • Supplement antibody-based approaches with orthogonal methods

  • Combine protein detection with gene expression analysis

  • Implement genetic approaches (e.g., mutant analysis) to confirm antibody-based findings

How can active learning approaches improve EXPB10 antibody development for challenging applications?

Recent advancements in antibody engineering and machine learning offer new possibilities for EXPB10 antibody development:

• Implementation of active learning strategies:

  • Begin with a small labeled subset of antibody variants

  • Iteratively expand the labeled dataset based on model uncertainty

  • Apply algorithms that effectively handle many-to-many relationships between antibodies and antigens

• Performance optimization:

  • Three recently developed algorithms have demonstrated significant improvements over random selection approaches

  • These methods can reduce the number of required antigen mutant variants by up to 35%

  • Learning acceleration can be achieved, with the best algorithm speeding up the process by 28 steps compared to random baseline approaches

• Out-of-distribution prediction improvement:

  • Active learning approaches particularly benefit scenarios where test antibodies and antigens are not represented in training data

  • This is especially relevant for highly specific applications of EXPB10 antibodies

• Experimental design implementation:

  • Design antibody engineering experiments based on active learning predictions

  • Prioritize testing of variants with highest uncertainty or information gain

  • Integrate computational and experimental cycles for efficient antibody optimization

What are the latest methodological advancements for using EXPB10 antibodies in plant allergen research?

Innovations in allergen research methodologies that can be applied to EXPB10 include:

• Epitope mapping technologies:

  • High-resolution epitope mapping using peptide microarrays

  • Structural epitope identification through hydrogen-deuterium exchange mass spectrometry

  • Computational prediction of conformational epitopes based on related allergens like Lol p 1

• Cross-reactivity assessment frameworks:

  • Systematic testing of EXPB10 antibodies against related grass pollen allergens

  • Identification of conserved epitopes across multiple species

  • Development of antibodies that either recognize or distinguish between cross-reactive epitopes

• Clinical relevance determination:

  • Correlation of antibody-defined epitopes with IgE binding in allergic patients

  • Basophil activation tests using antibody-defined EXPB10 epitopes

  • Competitive binding assays to map clinically relevant epitopes

• Therapeutic applications exploration:

  • Development of monoclonal antibodies that block IgE binding to EXPB10

  • Investigation of hypoallergenic variants based on antibody epitope mapping

  • Antibody-guided immunotherapy approaches

What are the optimal conditions for EXPB10 antibody storage and handling to maintain activity?

Based on information about similar recombinant proteins and antibodies, the following procedures are recommended:

• Long-term storage recommendations:

  • Store lyophilized antibodies at -20°C or lower for maximum stability

  • Avoid repeated freeze-thaw cycles, which can lead to protein denaturation

  • Consider storing working aliquots at 4°C for up to one month

• Buffer composition for stability:

  • For long-term storage, consider a Tris-based buffer with 50% glycerol as used for related proteins

  • Optimal pH range is typically 7.2-7.6

  • Addition of stabilizing proteins (BSA) at 0.1-1% can improve stability

• Working solution preparation:

  • Centrifuge the vial briefly before opening

  • Reconstitute lyophilized antibodies in sterile water or appropriate buffer

  • Prepare working dilutions on the day of the experiment for optimal results

• Quality control measures:

  • Periodically test antibody activity against reference standards

  • Monitor for signs of degradation (e.g., precipitation, loss of specificity)

  • Implement positive control experiments with each new aliquot

How can researchers design proper controls when using EXPB10 antibodies in complex plant tissue samples?

Robust experimental design requires comprehensive controls to ensure valid interpretation of results:

• Negative controls:

  • Include isotype-matched irrelevant antibodies

  • Use pre-immune serum from the same host species

  • Test tissues known not to express EXPB10 (based on EST database information showing EXPB10 is primarily expressed in pollen and anther-specific tissues)

• Specificity controls:

  • Pre-adsorb the antibody with recombinant EXPB10 to block specific binding

  • Include competitive binding with soluble EXPB10 protein

  • When available, use tissues from EXPB10 knockout/knockdown plants

• Cross-reactivity controls:

  • Test the antibody against recombinant EXPB11 (94% sequence identity)

  • Include other related expansins (EXPB1, EXPB9) as additional controls

  • Consider testing against Lol p 1 given its high sequence similarity (~70%)

• Procedural controls:

  • Include no-primary-antibody controls to assess secondary antibody specificity

  • Process some samples without any antibodies to identify potential autofluorescence

  • Include positive control samples with known EXPB10 expression

How do antibody binding profiles differ between EXPB10 and other expansin family members?

Understanding the differential binding profiles requires careful comparative analysis:

• Sequence-based epitope prediction:

  • Comparative sequence analysis of EXPB10, EXPB11, EXPB1, and EXPB9 reveals regions of high conservation versus divergence

  • EXPB10 and EXPB11 share 94% sequence identity, suggesting many shared epitopes

  • These proteins share ~62% sequence identity with EXPB1 and EXPB9, indicating greater epitope differences

  • Sequence comparison with Lol p 1 (~70% identity) can identify potential cross-reactive epitopes

• Domain-specific binding analysis:

  • Based on structural data from related expansins, EXPB10 likely consists of two domains:

    • Domain 1 with similarity to GH45 enzymes

    • Domain 2 with an immunoglobulin-like fold

  • Antibodies targeting Domain 1 may show greater specificity than those targeting the more conserved Domain 2

• Epitope mapping techniques:

  • Peptide arrays can identify linear epitopes unique to EXPB10

  • Competition assays with related expansins can reveal shared versus unique binding sites

  • Structural analysis informed by data from related proteins can predict conformational epitopes

What methodological approaches can determine the specific role of EXPB10 versus other expansins in cell wall dynamics?

Distinguishing the specific functions requires sophisticated experimental designs:

• Selective inhibition strategies:

  • Use highly specific antibodies to selectively inhibit EXPB10 function in wall extension assays

  • Compare with inhibition of other expansins to identify unique contributions

  • Design concentration-dependent inhibition experiments to quantify relative contributions

• Substrate specificity analysis:

  • Test EXPB10 binding to different cell wall components using antibody-based detection methods

  • Compare binding profiles with other expansins under identical conditions

  • Based on structural insights from related expansins, investigate EXPB10's interaction with arabinoxylan–cellulose networks

• Temporal and spatial expression analysis:

  • Use antibodies to track EXPB10 versus other expansin proteins during specific developmental processes

  • Correlate protein localization with cell wall changes using complementary techniques

  • Implement time-course studies to determine sequential activity of different expansins

• Genetic complementation approaches:

  • In plants with multiple expansin knockouts, test selective complementation with EXPB10

  • Use antibodies to verify protein expression in complementation lines

  • Correlate functional recovery with EXPB10 levels as detected by antibodies

How might novel antibody engineering approaches improve EXPB10 detection and functional analysis?

Emerging antibody technologies offer new possibilities for EXPB10 research:

• Single-domain antibody development:

  • Engineer camelid-derived nanobodies against EXPB10

  • These smaller antibody fragments may access epitopes restricted in dense cell wall environments

  • Their stability and small size make them ideal for in vivo applications in plant systems

• Bispecific antibody applications:

  • Develop bispecific antibodies targeting EXPB10 and its potential substrates

  • These could be used to detect proximity and interaction in complex cell wall environments

  • Such tools would be valuable for testing the proposed model of EXPB10 facilitating local movement and stress relaxation of polysaccharide networks

• Antibody fragments for improved penetration:

  • Engineer Fab or scFv fragments specific to EXPB10

  • These smaller fragments may improve tissue penetration in thick plant cell walls

  • They can be produced recombinantly in plant expression systems for cost-effective scale-up

• Antibody-based biosensors:

  • Develop FRET-based biosensors using EXPB10 antibodies to detect conformational changes during activity

  • Create split-reporter systems to detect EXPB10 interactions with cell wall components

  • Implement these tools for real-time imaging of EXPB10 activity in living plants

What integrated approaches combining antibody detection with other technologies will advance EXPB10 research?

Multi-faceted research strategies offer the most comprehensive understanding:

• Combined immunolocalization and live-cell imaging:

  • Correlate antibody-based detection of EXPB10 with dynamic cell wall changes

  • Integrate with fluorescent probes for cell wall components

  • Implement super-resolution microscopy to resolve nanoscale distributions and interactions

• Antibody-guided proteomics:

  • Use EXPB10 antibodies for immunoprecipitation followed by mass spectrometry

  • Identify interaction partners and post-translational modifications

  • Compare EXPB10 complexes isolated from different tissues or developmental stages

• Integration with structural biology:

  • Use antibody epitope mapping to inform structural models of EXPB10

  • Develop structural predictions based on the known crystal structure of related expansins like EXPB1

  • Test structural predictions with antibodies against specific domains or conformational states

• Systems biology framework:

  • Integrate antibody-derived data on EXPB10 expression and localization with transcriptomics, metabolomics, and cell wall analytics

  • Develop predictive models of cell wall dynamics incorporating EXPB10 function

  • Test model predictions using antibody-based detection and inhibition experiments